Literature DB >> 20069327

Graft-versus-host disease-related polymyositis.

Helene Maillard-Lefebvre1, Sandrine Morell-Dubois, Marc Lambert, Hilaire Charlanne, David Launay, Eric Hachulla, Ibrahim Yakoub-Agh, Pierre-Yves Hatron.   

Abstract

Chronic graft-versus-host disease (GVHD) sometimes mimics autoimmune diseases. We report the case of a 39-year-old patient who presented atypical polymyositis without elevated creatinine phosphokinase, related to a chronic GVHD following interruption of immunosuppressive treatment. Treatment with cyclosporine and corticosteroids resulted in complete and sustained remission of the polymyositis. The symptoms of chronic GVHD-related polymyositis are indistinguishable from those of idiopathic polymyositis. The context of transplantation and a decrease or interruption of prophylaxis suggest the diagnosis of GVHD-related polymyositis, especially if other manifestations of GVHD are associated. A suitably adapted treatment (association of corticotherapy and cyclosporine) improves polymyositis, and in most cases, a normal clinical state is achieved even if the symptoms were severe.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20069327     DOI: 10.1007/s10067-009-1350-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

Authors:  Jessica E Hoogendijk; Anthony A Amato; Bryan R Lecky; Ernest H Choy; Ingrid E Lundberg; Michael R Rose; Jiri Vencovsky; Marianne de Visser; Richard A Hughes
Journal:  Neuromuscul Disord       Date:  2004-05       Impact factor: 4.296

Review 2.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

Authors:  K M Sullivan; E Agura; C Anasetti; F Appelbaum; C Badger; S Bearman; K Erickson; M Flowers; J Hansen; T Loughran
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

3.  Acute polymyositis after donor lymphocyte infusion.

Authors:  Peng-Chan Lin; Liang-Tsai Hsiao; Po-Min Chen
Journal:  Eur J Haematol       Date:  2005-02       Impact factor: 2.997

Review 4.  Myositis associated with graft-versus-host disease.

Authors:  P M Parker; H Openshaw; S J Forman
Journal:  Curr Opin Rheumatol       Date:  1997-11       Impact factor: 5.006

Review 5.  Chronic graft-versus-host disease.

Authors:  Mitchell E Horwitz; Keith M Sullivan
Journal:  Blood Rev       Date:  2005-04-07       Impact factor: 8.250

6.  Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.

Authors:  P Cherin; S Herson; M C Crevon; J J Hauw; P Cervera; P Galanaud; D Emilie
Journal:  J Rheumatol       Date:  1996-07       Impact factor: 4.666

7.  Acute polymyositis following renal transplantation.

Authors:  Aisling E Courtney; Ciaran C Doherty; Brian Herron; Mark O McCarron; John K Connolly; J Ashley Jefferson
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

8.  [Clinical and myopathological findings in polymyositis].

Authors:  H Fukunaga; M Osame; I Sakashita; H Sameshima; A Igata
Journal:  No To Shinkei       Date:  1987-07

Review 9.  [Auto-immune-like disease post-bone marrow transplantation].

Authors:  S Vinzio; B Lioure; F Grunenberger; J-L Schlienger; B Goichot
Journal:  Rev Med Interne       Date:  2004-07       Impact factor: 0.728

Review 10.  Polymyositis as a manifestation of chronic graft-versus-host disease.

Authors:  A M Stevens; K M Sullivan; J L Nelson
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

View more
  8 in total

1.  Neuromuscular complications after hematopoietic stem cell transplantation.

Authors:  Susanne Koeppen; Abhiyrahmi Thirugnanasambanthan; Michael Koldehoff
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

Review 2.  A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.

Authors:  Fotios V Michelis; Vera Bril; Jeffrey H Lipton
Journal:  Int J Hematol       Date:  2015-03-03       Impact factor: 2.490

Review 3.  Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease.

Authors:  Sandhya Limaye; Vidya Limaye
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

4.  Polymyositis after donor lymphocyte infusion.

Authors:  Juan Montoro; Juan Carlos Hernández-Boluda; Cristina Arbona; Carlos Solano
Journal:  Int J Hematol       Date:  2012-08-19       Impact factor: 2.490

5.  Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment.

Authors:  Sooraj John; Scott J Antonia; Trevor A Rose; Robert P Seifert; Barbara A Centeno; Aaron S Wagner; Ben C Creelan
Journal:  J Immunother Cancer       Date:  2017-07-18       Impact factor: 13.751

6.  Polymyositis as a manifestation of chronic graft-versus-host disease after allo-HSCT.

Authors:  Lijuan Meng; Suqiong Ji; Qiong Wang; Bitao Bu
Journal:  Clin Case Rep       Date:  2018-07-12

7.  Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation.

Authors:  Matteo Chinello; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Paola Tonin; Gaetano Vattemi; Valeria Guglielmi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

8.  Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases.

Authors:  Sophia Golec; Emma Rabinovich; Mark Cohen; Linda Baer; Kamal Chamoun; Marcos de Lima
Journal:  Hematol Transfus Cell Ther       Date:  2019-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.